Pioneering discovery and therapeutics at the brain-vascular-immune interface
Cell · 2024-10 · 187 (21) · 5871-5876
DOI: 10.1016/j.cell.2024.09.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-10. Verfasst von Katerina Akassoglou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA 94158, USA; Gladstone Institute of Neurological Disease, San Franc…. Hauptthemen laut MEDLINE: Brain, Neuroinflammatory Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NINDS NIH HHS, BrightFocus Foundation.
Abstract (Originalsprache)
The brain-vascular-immune interface has emerged as a dynamic player in brain physiology and disease. We propose integrating vascular risk factors with genetic susceptibility as the nexus for the discovery of mechanisms and therapies for neuroinflammation, neurodegeneration, and neurorepair across polygenic neurologic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA 94158, USA; Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA; Department of Neurology, Weill Institute for Neur…
- Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Clevela…
- Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
- Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA 94158, USA; Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA; Department of Pediatrics, University of Californi…
- Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Basics in NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA 94158, USA; Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- BrightFocus Foundation
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Institute on Alcohol Abuse and Alcoholism
- German Research Foundation
Zitieren
APA
Akassoglou, K., Davalos, D., Mendiola, A. S., Petersen, M. A., Ryu, J. K., Schachtrup, C., & Yan, Z. (2024). Pioneering discovery and therapeutics at the brain-vascular-immune interface. Cell, 187(21), 5871-5876. https://doi.org/10.1016/j.cell.2024.09.018
Vancouver
Akassoglou K, Davalos D, Mendiola AS, Petersen MA, Ryu JK, Schachtrup C, et al. Pioneering discovery and therapeutics at the brain-vascular-immune interface. Cell. 2024;187(21):5871-5876. doi:10.1016/j.cell.2024.09.018
BibTeX
@article{Akassoglou2024,
author = {Akassoglou, Katerina and Davalos, Dimitrios and Mendiola, Andrew S and Petersen, Mark A and Ryu, Jae Kyu and Schachtrup, Christian and Yan, Zhaoqi},
title = {Pioneering discovery and therapeutics at the brain-vascular-immune interface},
journal = {Cell},
year = {2024},
volume = {187},
number = {21},
pages = {5871--5876},
doi = {10.1016/j.cell.2024.09.018}
}
EUVIMED